#ÀÎõ°ú¹Î¼º¹æ±¤, #ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°, #ÀÎõ¹æ±¤¿°, #°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø, #¹æ±¤¿°ÇÑÀÇ¿ø, #ÀÎõ¹æ±¤¿°, #±¸¿ùµ¿°ú¹Î¼º¹æ±¤
ÀÎõ°ú¹Î¼º¹æ±¤,,ÀÎõ°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°,,ÀÎõ¹æ±¤¿°,,°ú¹Î¼º¹æ±¤ÇÑÀÇ¿ø,,¹æ±¤¿°ÇÑÀÇ¿ø,,ÀÎõ¹æ±¤¿°,,±¸¿ùµ¿°ú¹Î¼º¹æ±¤
¾È³çÇϼ¼¿ä. ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä
ÀÎõ°ú¹Î¼º¹æ±¤ ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ÀÎõÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¹æ±¤¿°, °£Áú¼º¹æ±¤, ¼ºÀξߴ¢Áõ, ¹æ±¤¿°Ä¡·á, ¾ß´¢Áõ, ÀÜ´¢°¨, ¿©Àڹ汤¿°Áõ»ó, °£Áú¼º¹æ±¤¿°, ³²ÀÚÀÜ´¢°¨, ºÓÀº¼Òº¯, ¿©¼ºÀÜ´¢°¨, ¼Òº¯Ç÷´¢, ³²Àڹ汤¿°, Áú¿°ÀÜ´¢°¨, ¾î¸°ÀÌ¿ÀÁܼÒÅÂ, ÀÓ½ÅÁß¿ÀÁܼÒÅÂ, ¿ä½Ç±Ý, ¼Ò¾Æ¹æ±¤¿°, Àý¹Ú´¢, °ú¹Î¼º¹æ±¤, ¿©Àڹ财Åë, ºó´¢, Àü¸³¼±, ¹æ±¤¿°¼Òº¯, ¸¸¼º¹æ±¤¿°µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.
¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδë°È, ¼ÒÇÕÇâ¿ø, ¿Â¿Ä¡·á, ¸¶»çÁö, ±ÙÀ̿Ͼàħ, ¾îÇ÷¾àħ, ¸Å¼±¿ä¹ý, µµÀο¿ä¹ý, ÁßdzÁ¶±â°ËÁø, Çâ±â¿ä¹ý, ´Ü¼ø¿îµ¿Ä¡·á, ½½¸µ, ·Ñ¸µ, ³Ã¿Â¿å, mechanical therapy, paraffin, Àü±âÀÚ±ØÄ¡·á, Çdz»Ä§, ü¿Áø´Ü±â, ¾Æ·Î¸¶Å׶óÇÇ, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù
¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼ Áø·áÁßÀÌ¸ç ºÎ»ê »çÇϱ¸ ´Ù´ë1µ¿, Àü³² ¿©¼ö½Ã °øȵ¿, ¿ï»ê ºÏ±¸ »êÇϵ¿, Àü³² ±¸·Ê±º ±¤ÀǸé, °æ³² ÀǷɱº Ä¥°î¸é, ÀüºÏ ÀÍ»ê½Ã ÆȺÀµ¿, ÀÎõ °è¾ç±¸ µ¿¾çµ¿, ºÎ»ê ±ÝÁ¤±¸ ȸµ¿µ¿, °æ±â ¾È¼º½Ã ¼Àε¿, °æ³² ±èÇؽà ¾î¹æµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ »ó³²µ¿, ºÎ»ê ¿µµµ±¸ ¿µ¼±µ¿3°¡, ÃæºÏ ÃæÁֽà ÁÖ´öÀ¾, °æºÏ ¹®°æ½Ã »ê¾ç¸é, Àü³² ¸ñÆ÷½Ã ÃøÈĵ¿, °æ³² °ÅÁ¦½Ã °ÅÁ¦¸é, ¿ï»ê Áß±¸ ¿Á±³µ¿, °¿ø °¸ª½Ã ȸ»êµ¿, Àü³² ¸ñÆ÷½Ã Ãູµ¿1°¡, °æ±â ¾È¼º½Ã ±Ý¼®µ¿, ºÎ»ê ºÏ±¸ È¸íµ¿, Àü³² ³ªÁֽà »ï¿µµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ¼ºÈ£µ¿, °¿ø ö¿ø±º ±Ù³²¸é, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¼®¼ö3µ¿, Àü³² ¿µ±¤±º ´ë¸¶¸é, °æ³² »çõ½Ã À̱ݵ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ »ïõµ¿2°¡, ¿ï»ê ºÏ±¸ ´Þõµ¿, ÀÎõ °È±º ¾ç»ç¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼ ³»¿øÇÏ°í °è½Ê´Ï´Ù
ÀÎõ°ú¹Î¼º¹æ±¤Ä¡·á ãÀ¸½Ã´Â ÀÎõ³íÇöµ¿, ¹è°ð½Åµµ½Ã, ûÇе¿, ¿ëÇöµ¿, µ¿ÀÎõ, ¼þÀǵ¿, À²¸ñµ¿, °è¾ç±¸, ¿ëÀ¯µµ, °¡Á¤µ¿, °£¼®µ¿, ³íÇö°íÀܵ¿, ¼Û¸²µ¿, ºÎõ, µ¿±¸, Áßµ¿, °ü±³µ¿, Á־ȿª, °Ë¾Ï, ¿µÁ¾Çϴõµ½Ã, ¼Ò·¡Æ÷±¸, ³²µ¿±¸, °¡Áµ¿, ºñºÀ¸é, µµ¸²µ¿, ÀÎõÁÖ¾È, ³²¾çÀ¾, ¹®Çе¿, ÀÎõ, ¼±Çе¿, ÀÎõ³íÇö, ¹è°ð, ±¸¿ùµ¿, ¼Ûµµ±¹Á¦µµ½Ã, Áß±¸ µî ÀÎõ Áö¿ª Áֹε鲲¼ ¹Ì¿ÃÇÑÀÇ¿øÀÎõÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.
´õ »ìÆ캸±â
1. Gammie A, Kaper M, Dorrepaal C, et al. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol 2016; 69:361.
2. Herzog AR, Diokno AC, Brown MB, et al. Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc 1994; 42:264.
3. Minassian VA, Bazi T, Stewart WF. Clinical epidemiological insights into urinary incontinence. Int Urogynecol J 2017; 28:687.
4. Brown JS, Nyberg LM, Kusek JW, et al. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol 2003; 188:S77.
5. Milson I, Altman D, Lapitan, et al.. Epidemiology of urinary and faecal incontinence and pelvic organ prolapse. In: Incontinence, 4th ed., Abrams P, Cardozo L, Khoury S, Wein A (Eds), Health Publications Ltd., Plymouth, UK 2009. p.35.
6. Robinson D, Hanna-Mitchell A, Rantell A, et al. Are we justified in suggesting change to caffeine, alcohol, and carbonated drink intake in lower urinary tract disease? Report from the ICI-RS 2015. Neurourol Urodyn 2017; 36:876.
7. Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101:1388.
8. www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/Downloads/Eligible-Providers-2014-Proposed-EHR-Incentive-Program-CQM.pdf (Accessed on April 06, 2015).